Raise closed, search for fresh raises on Seedstage

Cambridge, MA

Developing wearable smart textiles for real-time cardiovascular monitoring and telemedicine.

• Smart textile technology: Clothing embedded with 128 sensors transmitting real-time cardiovascular data.
• Clinically validated prototypes: Successfully tested in major hospitals in Boston and Paris.
• Strategic collaborations: Developed with MIT engineers and top cardiologists from renowned hospitals.
• Market focus: Targeting the $265 billion telemedicine market with plans to expand into sports and military applications.
• Patient-centered model: Enables continuous, remote health evaluations owned by the patient.

Lexington Biomedical is developing Biowear, a smart textile technology designed for cardiovascular telemedicine and remote health monitoring. This technology integrates 128 invisible sensors into comfortable clothing such as T-shirts and sports bras, enabling real-time transmission of high-resolution 12 to 18-lead electrocardiograms (EKGs) along with additional biometric data including blood pressure, respiration, hydration, oxygen saturation, and sleep quality. Created through collaboration between MIT engineers and leading cardiologists from Mass General Brigham Hospitals and La Pitié – Salpêtrière Hospital, Biowear aims to deliver medical-grade diagnostic data outside of hospital settings, bringing early detection and continuous monitoring capabilities directly to patients.

With prototypes successfully tested in four major hospitals in Boston and Paris, Biowear has been recognized by top cardiologists for its potential to improve cardiovascular care. Lexington Biomedical’s business model focuses initially on hospitals and clinics, offering a patient-owned system that supports timely, remote evaluations and enhances telemedicine capabilities. As the telemedicine market is projected to reach $265 billion by 2025, the company also anticipates expanding Biowear’s applications into military, sports performance, and wellness sectors. Lexington Biomedical is using this fundraising round to continue product development, pursue regulatory approvals, and transition from prototype to commercial launch, aiming to partner with leading hospitals in the U.S. and Europe.

Company Info

Lexington Biomedical develops smart textiles that provide real-time cardiovascular monitoring for telemedicine and health applications.

Lexington Biomedical develops smart textile technology designed for cardiovascular telemedicine applications. Their primary product, Biowear, is a T-shirt or sports bra embedded with 128 invisible sensors that provide real-time, high-resolution 12 to 18-lead electrocardiograms (EKGs) and other biometric data such as blood pressure, respiration, hydration, oxygen saturation, and sleep quality. The technology integrates microelectronics, smart textiles, artificial intelligence, and digital signal transmission to enable remote cardiovascular monitoring with medical-grade accuracy, enhancing telemedicine consultations and remote patient care. Fully functional prototypes have been tested at leading hospitals in Boston and Paris, demonstrating its potential use in both medical and sports performance contexts.

Biowear aims to address the limitations of traditional cardiovascular monitoring, which typically requires hospital visits, by providing continuous, on-demand diagnostic data from the comfort of everyday clothing. The solution is intended to offer early detection and monitoring of cardiovascular conditions like arrhythmias and heart failure, improving patient outcomes and reducing healthcare costs. Initially targeting hospitals and clinics, Lexington Biomedical plans to expand into military, sports, and wellness applications. The company collaborates with cardiologists from institutions such as Mass General Brigham and Harvard Medical School and has attracted significant interest from major healthcare centers.